Kelly Nelson Kelly to Cyclooxygenase Inhibitors
This is a "connection" page, showing publications Kelly Nelson Kelly has written about Cyclooxygenase Inhibitors.
Connection Strength
0.152
-
PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age. J Pediatr. 2019 02; 205:41-48.e6.
Score: 0.152
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.